Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials

J. I. Silverberg*, E. L. Simpson, M. Ardeleanu, D. Thaçi, S. Barbarot, J. Bagel, Z. Chen, L. Eckert, J. Chao, A. Korotzer, E. Rizova, A. B. Rossi, Y. Lu, N. M.H. Graham, T. Hultsch, G. Pirozzi, B. Akinlade

*Corresponding author for this work

Research output: Contribution to journalArticle

15 Scopus citations

Fingerprint Dive into the research topics of 'Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials'. Together they form a unique fingerprint.

Medicine & Life Sciences